Market Overview

Allergan On The Acquisition Hunt

Share:
Related AGN
A Peek Into The Markets: U.S. Stock Futures Surge Ahead Of GDP Report
Allergan Says New Research Indicates New Attitude To Beauty As Women Seek To Score Over Youth On Confidence
Precious Metals Set To Rise Again (Seeking Alpha)

Allergan (NYSE: AGN) is potentially looking at Salix Pharmaceuticals (NASDAQ: SLXP) and at least one additional company about an acquisition, The Wall Street Journal reported, as Allergan looks to fight off a hostile takeover bid from Valeant Pharmaceuticals.

Shares of Salix Pharmaceuticals exploded higher on the news, jumping from $139.50 before the news to briefly over $154 after the story broke. Shares recently traded up 9.62 percent at $152.52.

Related Link: JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

Shares of Jazz Pharamaceuticals (NASDAQ: JAZZ) moved in sympathy on the news, trading higher by three percent.

Posted-In: News Wall Street Journal Movers Media

 

Related Articles (AGN)

View Comments and Join the Discussion!